Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.Blood Advances|November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantationMadhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.The Lancet. Haematology|December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 studyMichael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.The Journal of Clinical Investigation|November 6, 2019
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantationSusan Prockop, Ekaterina Doubrovina, Stephanie Suser, et al.Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.Cancer Discovery|February 13, 2018
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid LeukemiaFiona C Brown, Eric Still, Richard P Koche, et al.Nature Medicine|October 6, 2015
Loss of BAP1 function leads to EZH2-dependent transformationLindsay M LaFave, Wendy Béguelin, Richard Koche, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.Cancer Cell|July 16, 2015
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative NeoplasmsSara C Meyer, Matthew D Keller, Sophia Chiu, et al.Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.Pageof 5